BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26855522)

  • 1. Neoadjuvant chemotherapy in oral cancers: Selecting the right patients.
    Vishak S; Rangarajan B; Kekatpure VD
    Indian J Med Paediatr Oncol; 2015; 36(3):148-53. PubMed ID: 26855522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of neoadjuvant chemotherapy as compared to upfront surgery for the management of oral squamous cell carcinoma: a systematic review and meta-analysis.
    Kende P; Mathur Y; Varte V; Tayal S; Patyal N; Landge J
    Int J Oral Maxillofac Surg; 2024 Jan; 53(1):1-10. PubMed ID: 37088590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive Surgery after Neoadjuvant Chemotherapy for Locally Advanced Oral Cavity Cancers: Experience from a Tertiary Care Center.
    Agrawal M; Konduru V; Riju J; Singh A; Joel A; Karuppusami R; Tirkey AJ
    South Asian J Cancer; 2023 Oct; 12(4):341-348. PubMed ID: 38130286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
    Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A
    J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial.
    Kartini D; Taher A; Panigoro SS; Setiabudy R; Jusman SW; Haryana SM; Abdullah M; Rustamadji P; Purwanto DJ; Sutandyo N; Suroyo I; Siregar BH; Maruli H; Sungkar S
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):12. PubMed ID: 32372215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Impact of Surgical Resection in Locally Advanced T4b Oral Squamous Cell Carcinoma.
    Gangopadhyay A; Bhatt S; Nandy K; Rai S; Rathod P; Puj KS
    Laryngoscope; 2021 Jul; 131(7):E2266-E2274. PubMed ID: 33459389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.
    Cao XF; He XT; Ji L; Xiao J; Lv J
    Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.
    Kranzfelder M; Schuster T; Geinitz H; Friess H; Büchler P
    Br J Surg; 2011 Jun; 98(6):768-83. PubMed ID: 21462364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcome of locally advanced oral squamous cell carcinoma.
    Bera RN; Tandon S; Singh AK; Boojar FMA; Jaiswal G; Borse S; Pal US; Sharma NK
    Natl J Maxillofac Surg; 2023; 14(2):185-189. PubMed ID: 37661995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.
    Gillen S; Schuster T; Meyer Zum Büschenfelde C; Friess H; Kleeff J
    PLoS Med; 2010 Apr; 7(4):e1000267. PubMed ID: 20422030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic Adenocarcinoma.
    Keane FK; Wo JY; Ferrone CR; Clark JW; Blaszkowsky LS; Allen JN; Kwak EL; Ryan DP; Lillemoe KD; Fernandez-Del Castillo C; Hong TS
    Am J Clin Oncol; 2018 Jun; 41(6):607-612. PubMed ID: 27740973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer].
    Scheufele F; Friess H
    Chirurg; 2020 May; 91(5):391-395. PubMed ID: 31965198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher overall survival rates of oral squamous cell carcinoma treated with metronomic neoadjuvant chemotherapy.
    Kina S; Miyamoto S; Kawabata-Iwakawa R; Kina-Tanada M; Ogawa M; Yokoo S
    Am J Cancer Res; 2024; 14(3):1033-1051. PubMed ID: 38590400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study.
    He W; Wang C; Wu L; Wan G; Li B; Han Y; Li H; Leng X; Du K; Chen H; Wang Q; Peng L
    Front Immunol; 2022; 13():853922. PubMed ID: 35720312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for locally advanced head and neck squamous cell carcinoma - Is it still relevant? A practice pattern survey among oncologists of India.
    Bandyopadhyay A; Goswami U; Ghosh P; Das P; Mandal S
    J Cancer Res Ther; 2023; 19(5):1316-1323. PubMed ID: 37787301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.
    Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH
    Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant radiotherapy/chemoradiotherapy in locally advanced non-small cell lung cancer.
    Yalman D
    Balkan Med J; 2015 Jan; 32(1):1-7. PubMed ID: 25759765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
    Zhang GY; Zhang R; Bai P; Li SM; Zhang YY; Chen YR; Huang MN; Wu LY
    BMC Cancer; 2022 Dec; 22(1):1331. PubMed ID: 36539745
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.